Covered recipient · General Payments record
LISA MARIE DIAZ
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,167.27
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $487.25 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $119.60 | 1 |
| Lilly USA, LLC | $86.69 | 4 |
| ABBVIE INC. | $76.40 | 3 |
| LEO Pharma Inc. | $70.94 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.59 | 2 |
| Amgen Inc. | $39.72 | 2 |
| Verrica Pharmaceuticals Inc. | $24.24 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.30 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103638208 | CMS |
| ABBVIE INC. | $26.14 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103638210 | CMS |
| ABBVIE INC. | $25.96 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103638212 | CMS |
| Amgen Inc. | $25.92 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117238971 | CMS |
| Amgen Inc. | $13.80 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117238973 | CMS |
| LEO Pharma Inc. | $25.46 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152626303 | CMS |
| LEO Pharma Inc. | $22.74 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152626305 | CMS |
| LEO Pharma Inc. | $22.74 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152626307 | CMS |
| Lilly USA, LLC | $20.77 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135145227 | CMS |
| Lilly USA, LLC | $15.37 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135131132 | CMS |
| Lilly USA, LLC | $27.19 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135155707 | CMS |
| Lilly USA, LLC | $23.36 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135135558 | CMS |
| Novartis Pharmaceuticals Corporation | $21.34 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086936413 | CMS |
| Novartis Pharmaceuticals Corporation | $25.25 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086936435 | CMS |
| PFIZER INC. | $119.60 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131897835 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.07 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114037699 | CMS |
| Verrica Pharmaceuticals Inc. | $24.24 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118379672 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.